Obese Patients Flashcards

1
Q

BMI

Formula?

Doesn’t differentiate between: (2)

A

weight (kg)/ height2 in meters = kg/m2

Doesn’t differentiate between
1. Overweight and overfat
2. Waist circumference, waist-hip ration, age

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
1
Q

Distribution of Fat:
-Which one has CV disease?
-Which one has ^ O2 consumption?
-Metabolic?

Android? ____ Obesity

Gynecoid? ____ Obesity

A

Android
* “central” obesity
* Upper body (truncal)
* Associated with ↑ oxygen consumption/cardiovascular dz

Gynecoid
* “peripheral” obesity
* Hips, buttocks, thighs
* Less metabolically active
* Not really associated with CV disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Common associated diseases
(8)

Lungs (2)
<3: (2)
Endocrine: (2)
Muscular skeletal (1)

A

Common associated diseases
1. Type 2 diabetes mellitus
2. Obstructive sleep apnea
3. Asthma
4. Chronic obstructive pulmonary disease
5. Hypertension
6. Cardiovascular disease
7. Cancer
8. Osteoarthritis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Cardiac

Volume to weight ratio: _____ ml/kg

^CO due to:
1.) Excess fat: ____ ml/kg excess body fat
2.)
3.)

Cardiac Dysrhythmias
What kind (2):
Cause: (2):

A

Total blood volume increased
* On a volume-to-weight ratio is lower 50ml/kg
* Most distributed to adipose tissue

↑ Cardiac output
1.) 20-30ml/kg of excess body fat
2.) d/t LV dilation
3.)↑ stroke volume

Cardiac dysrhythmias
* d/t fatty infiltrates of conduction system, and CAD
* Low QRS voltage, LVH, left axis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Hematologic system

Hypercoagulability: Increase in:
1.)
2.)
3.)
4.)

  • Endothelial dysfunction bc increase:
    1.)
    2.)
A
  • Hypercoagulability
  • ↑er levels of: …… 7,8,v,f
    1.) fibrinogen
    2.) Factor VII,
    3.) Factor VIII
    4.) von Willebrand

–> Endothelial dysfunction 8v
* d/t levels of factor VIII (8) and von Willebrand

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

GI system

___: Gastric volume
___: Gastric acidity
___: Gastric emptying
___: Intra-gastric pressure
____: LES and hiatal hernia formation

Aspiration risk for asp. pneumonitis:
Volume >___ mL
pH <____

A

^: Gastric volume
^: Gastric acidity
Delayed: gastric emptying
^ : Intra-gastric pressure
Relax: LES and hiatal hernia formation

Aspiration risk for asp. pneumonitis:
Volume >___ mL
pH <____

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Renal system

Glomerular ___filtration
___: RBF
___: Renal Tubular reabsorption
_____: Renin-angiotensin system
_____:Natriuresis (excretion of Na)

A

Glomerular HYPER-filtration
↑ RBF
^: Renal tubular reabsorption

Activates: renin-angiotensin sys
Impairs: Natriuresis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Endocrine system

___: SNS activity
___: Insulin resistance
_______: glucose metabolism
_____: pressor activity of norepi and angiotensin II
_____:Sodium retention
____:Thyroid hormone resistance

_____thyroidism in 25% of morbidly obese patients

A

^: SNS
^: Insulin resistence
Impaired glucose metabolism

^ enhanced: pressor activity of NE/ATII

Sodium retention

Thyroid hormone resistence

hypothyroidism in 25% of morbidly obese patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Metabolic Syndrome

3 of these for diagnosis

A
  • Abdominal obesity
  • Decreases levels of HDL
  • Hypertriglyceridemia
  • Hyperinsulinemia
  • Glucose intolerance
  • Hypertension
  • Proinflammatory state
  • Prothrombotic state
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Risk Factors for Metabolic Syndrome:
___ age
Men or women
___race

What meds??
(4)

A

Risk factors
* Increased age
* Men > women
* Hispanics and South Asians

  • Chronic corticosteroids
  • Antidepressants
  • Antipsychotics
  • Protease inhibitors: viral meds
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Metabolic Syndrome = increased risk of:

(5)
<3, endo, repro, liver

____% resolved with weight loss surgery

A
  • Cardiovascular disease
  • Type 2 diabetes mellitus
  • Polycystic ovary syndrome
  • Nonalcoholic fatty liver disease
  • Improper immune responses
  • 98% resolved with bariatric surgery/weight loss goal
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Obstructive sleep apnea and
hypopnea syndrome (OSAHS)

  • OSA
  • Hypopnea

both last how long??
how much x per hr?
decrease sat by__%?

A

OSA
* Complete cessation of breathing
* Lasting 10 seconds or >
* 5x or > each hour of sleep
* Decreased sat 4%

Hypopnea
* Reduction in airflow 50% or >
* Lasting 10 seconds or >
* 15 x or more/hour of sleep
* Decreased sat 4%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Sleep study for OSAHS

Polysomnography:
Mild=
Moderate=
Severe=

Treatment =CPAP. bc risk of:
(4)

A

Reported as: apnea/hypopnea index (AHI)= total # of events/total sleep time

  • Mild: 5-15/hr
  • Moderate: 15-30/hr
  • Severe: > 30/hr

Risk of:
* Systemic/Pulmonary HTN
* LVH
* Cardiac dysrhythmias
* Cognitive impairment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Obesity hypoventilation syndrome
* Aka: Pickwickian syndrome

-Results from: _______
-___% of morbid obesity

Results in:
Resp =

Diagnosis??
(2)

A
  • Results from long-term OSA…5-10% of morbidly obese

Results in:
* Pulmonary hypertension
* Cor pulmonale

  • Diagnosis
  • BMI > 30 kg/m2
  • Awake hypercapnia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Drug Dosing Guidelines:

Based on IBW: (4)
Based on TBW: (5) —- pain?
Based on tissue solubility;

A

Based on IBW
* Propofol
* Vecuronium
* Rocuronium
* Remifentanil

Based on TBW
* Midazolam
* Succinylcholine
* Cisatracurium
* Fentanyl
* Sufentail

Based on tissue solubility
* Desflurane probably favored…

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Phentermine

Function?
FDA for ___ months

Symptoms:

A
  • Sympathomimetic which ↓ appetite
  • FDA approved for only 3 months

Tachycardia, palpitations, hypertension

dependence, abuse

  • No longer in combo with Fenfluramine
16
Q

Orlistat

Function?

S/E:
Chronic use –> _____ (3)

A
  • Blocks absorption of dietary fat

Side Effects
Liquid stool, oily spotting, fecal urgency, flatulence, abdominal cramps

Chronic Use:
1.) Fat soluble vitamin deficiencies
2.) Possible Vit K deficiency… = ^BLEEDING
3.) prolonged PT

17
Q

OTC Herbals

Pancreatic lipase inhibitors… (2)

Appetite suppressors… (3)

Energy stimulants…(1)

Regulate lipid metabolism… (3)

A

OTC Herbals

Pancreatic lipase inhibitors…
* caffeine, green tea

Appetite suppressors…
* ginseng, ephedra, sunflower oil

Energy stimulants…
* acai berry

Regulate lipid metabolism…
* soybean, fish oil, oolong tea

18
Q

___ response with opioids/prop/benzos

What short acting pain drugs are favored?
What alpha 2 agonist favored?

VA: effect on breathing??
What gas is NOT favored?

A

Exaggerated responses (especially in pts with OSA)

remi/fentanyl most favored

α2 agonists…dexmedetomidine

  • Decrease pharyngeal musculature
  • Decreased airway patency

-Diminish ventilatory response to CO2
-Nitrous not favored d/t high oxygen demand in pts

19
Q
  • ___ vital capacity
  • ___ inspiratory capacity
  • ___ expiratory reserve volume
  • ___ functional residual capacity
  • ____compliance
  • Closing capacity is close to or within tidal breathing
  • Especially when supine/recumbent
  • Rapid desaturation
A
  • ⬇️ vital capacity
  • ⬇️ inspiratory capacity
  • ⬇️ expiratory reserve volume
  • ⬇️ functional residual capacity
  • Low compliance
  • Closing capacity is close to or within tidal breathing
  • Especially when supine/recumbent
  • Rapid desaturation
20
Q
  • Increased adipose deposited:
    1.
    2.
    3.
    4.
    5.
    6.
A
  • Increased adipose deposited into
    1. Uvula
    2. Tonsils
    3. Tonsillar pillars
    4. Tongue
    5. Aryepiglottic folds
    6. Lateral pharyngeal walls
21
Q
  • Changes oropharynx into an ellipse  Short transverse/long AP axis
  • Inverse relationship between degree of obesity and pharyngeal area
A
22
Q

Predictors of difficult intubation:

  1. BMI?
  2. Mouth?
  3. Teeth?
  4. Neck
  5. Mandible?
A

Predictors of difficult intubation:

  1. BMI not necessarily an independent predictor
  2. Small mouth opening
  3. Large/protuberant teeth
  4. Limited neck mobility
  5. Retrognathia (unusual mandible position)
23
Q
  • In an effort to prevent atelectasis and desaturation:
  • Preoxygenation with:
  • Positioning head: _____ degrees
  • 30 degrees reverse Trendelenburg even better
  • Recruitment maneuvers then PEEP ____.
A

CPAP during preoxygenation… 10cm H20

25-30 degrees head up for obese patients

  • 30 degrees reverse Trendelenburg even better

PEEP 10 cm and vent after ventilation

24
Q

What to do for aspiration risk?

Meds?
Type of intub?

A
  • Histamine receptor agonists
  • Proton pump inhibitors: “-prazole”
  • RSI
  • Awake fiberoptic intubation
25
Q

Regional Anesthesia

Advantages (4)

Difficult so do what:

A
  • Less airway manipulation
  • Fewer cardiopulmonary depressants
  • ↓ chance of PONV
  • Better postop pain control (at least initially)

Technically difficult:
* Longer needles
* Different ultrasound probes= use curve
* Smaller doses (epidurals) d/t smaller space…cephalad spread
* Higher rates of block failure
* Higher rates of hypotension after block d/t IVC/Ao compression

26
Q

Monitoring:

Cuff too small? BP false elevated

Bladders should circle at least ____% of circumference

Pul HTN/Pul art cath/ TEE

Hard IV??
High Risk for DVT/PE?

A

Anesthetic technique: Monitoring
* Proper size cuff
* BP falsely elevated if cuff too small
* Bladders should circle at least 75% of circumference
* Needs stem from comorbidities (often occurring with obesity)
* Pulmonary hypertension…pulmonary artery catheter or TEE

  • Difficult IV access…central line placement
  • High risk of DVT and PE…IVC filter
  • Difficult non-invasive BP…arterial line
  • Need to monitor
    ventilation/ABG’s…arterial line
27
Q

Days Prior to Surgery:

Continue or D/C GLP-1 agonist:__?
Daily use?
Weekly use?

With GI symptoms?
Without GI symptoms

A
  • For patients on daily dosing consider holding GLP-1 agonists on the day of the procedure/surgery.
  • For patients on weekly dosing consider holding GLP-1 agonists a week prior to the procedure/surgery.

GI symptoms –> Delay elective surgery

No GI symptoms and HELD –> Ultrasound check

28
Q

PRE-OP EVAL:

If CPAP use is _____ = Difficult mask ventilation

DO NOT CONTINUE THESE HOME MEDS:
(3)

A
  • CPAP usage of > 10cm H2O suggests difficult mask ventilation

Focus on evidence of:
* Hypertension
* Diabetes
* Heart failure
* Hypoventilation syndrome

DO NOT CONTINUE:
-antihypertensives, insulin, oral -hypoglycemics

29
Q

POST-OP

Dose base on IBW or TBW?

What vent mode during emergence

What are some non-opioid/opiod sparing??

A

Sit up

Full reverse neuromuscular blockade. Dose on IBW or TBW?? TBW (google)

During emergence, PRESSURE SUPPORT

Home = CPAP

Non-opioid or opioid sparing
* Tramadol
* Dexmedetomidine
* Ketamine
* Clonidine